tetraSILVER® Works Like Magic, But It’s Based on Solid Science.

tetraSILVER Silver Oxide was discovered after years of extensive research. With four silver atoms and four oxygen atoms, it is considered earth’s most powerful molecular combination of silver and oxygen. As a result, several international patents have been awarded, with additional patents pending.

 

 
         
 

Test Data

tetraSILVER has been studied for over 10 years, showing that it is, both, very effective and very safe in skin care applications.

In-Vitro Testing:

"In-vitro" means an artificial environment created outside a living organism (e.g., a test tube or culture plate) used in experimental research to study a disease or process. Before tetraSILVER became our products’ unique ingredient it was tested by 14 independent research labs against gram-negative bacteria, gram-positive bacteria, fungi, yeast, and viruses. The labs included Quintiles, Parexel, MDS/Pharma, and other world renowned research organizations. Test after test documented the powerful antimicrobial properties of tetraSILVER.
 

Toxicity Testing:

In 1966, the US Environmental Protection Agency (EPA) approved tetraSILVER as an effective disinfectant in swimming pools, after extensive tests showed this Silver Oxide was capable of quickly killing a wide spectrum of germs. In the same series of studies, the EPA also determined that TetraSILVER was safe, after passing a series of oral (swallowing), dermal (skin), and ocular (eye) toxicity tests. These tests were very important because some people are in pools every day.
 

Clinical Testing:

Initial clinical investigations with 328 people (conducted by research dermatologists), in addition to reports from doctors throughout the world, strongly suggest that TetraSILVER, as a key ingredient in skin care products, provides outstanding benefits and supports the body's ability to quickly resolve many common skin problems. 
 
         
 

Patents

Several patents and patents pending protect the company’s intellectual property relative to skincare and topical applications.

  1. Compositions using tetrasilver tetroxide and methods for management of skin conditions using same; Patent # 6,669,966; Issued December 30, 2003

  2. Multivalent electron active compositions and methods of making and using same; Patent # 6,645,531; Issued November 11, 2003

  3. High performance silver (I,III) oxide antimicrobial textile articles; Patent # 6,436,420; Issued August 20, 2002

  4. High performance cobalt (II,III) oxide antimicrobial textile articles; Patent # 6,228,491; Issued May 8, 2001

  5. Tetrasilver tetroxide treatment for skin conditions; Patent # 6,258,385; Issued July 10, 2001

  6. Compositions and methods for facilitating skin growth and managing skin conditions; PCT Int'l Patent Application # PCT/US00/29115; Filed October 20, 2000

  7. Molecular crystal redox device for pharmaceuticals; Patent # 5,571,520; Issued November 5, 1996

  8. Molecular crystal device for pharmaceuticals; Patent # 5,336,499; Issued August 9, 1994

 
         
 

Privacy  |  Terms of Use  |  Site Map
Products  |  Ingredients  |  tetraSILVER  |  Action  |  Resources  |  Precautions  |  FAQs

 
         
© 2003-2007 Aidance Skincare & Topical Solutions LLC.
Aidance®, tetraSILVER®, Tetrasil®, Pedi-Cure®, Genisil® and Electron-Jumping Compound® are registered trademarks of Aidance Skincare. Femmesil™ and Safe Lips™ are trademarks of Aidance Skincare. Aidance Skincare products are protected by US and international patents granted and pending including US 6669966, US 6645531, US 6258385, and PCT/US00/29115.

Aidance products are cosmetics whose ingredients appear in the Cosmetic, Toiletry & Fragrance Association’s International Cosmetic Ingredient Dictionary and Handbook. Aidance products are not intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease. Aidance products are intended for the cleansing, beautifying and moisturizing of the human body. Neither FDA nor any other US regulatory body approves cosmetics and therefore Aidance products have not been evaluated or approved by the US Food and Drug Administration (FDA) or any other regulatory agency.